Traditional Chinese medicine-derived monomers improve bone metabolic imbalance and delay osteoporosis progression by regulating mitochondrial homeostasis (opens in new tab)
Osteoporosis is a systemic metabolic bone disease characterized by reduced bone mass, microarchitectural deterioration, and increased fracture risk. Its pathogenesis is driven by an imbalance between insufficient osteoblast-mediated bone formation and excessive osteoclast-mediated bone resorption. In recent years, mitochondrial homeostasis has emerged as an important pathological hub in this process. Beyond energy production, mitochondria regulate redox balance, mitophagy, apoptosis, senescen...
Read the original article